Arsenal Bio

ArsenalBio raises $325M in one of the year’s largest biotech funding rounds
BioPharma Dive
Wed, 09/4/24 - 11:46 am
Arsenal Bio
funding
biotech
cell therapy
ovarian cancer
kidney cancer
Roche
Bristol Myers Squibb
BMS-backed Arsenal Bio pulls trigger on $220M series B, touting potential fleet of gene-edited cell therapies
Fierce Biotech
Tue, 09/6/22 - 10:39 am
Arsenal Bio
Bristol Myers Squibb
funding
cell therapy